
Eric K. Nicholson
Examiner (ID: 1800)
| Most Active Art Unit | 3501 |
| Art Unit(s) | 3508, 3642, 2899, 3744, 3501, 3627, 3629, 3626, PQT, 3679 |
| Total Applications | 2110 |
| Issued Applications | 1732 |
| Pending Applications | 114 |
| Abandoned Applications | 263 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 11977615
[patent_doc_number] => 20170281769
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-05
[patent_title] => 'STABLE ANTI-IL-4Ra FORMULATION'
[patent_app_type] => utility
[patent_app_number] => 15/508647
[patent_app_country] => US
[patent_app_date] => 2015-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 44645
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15508647
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/508647 | STABLE ANTI-IL-4Ra FORMULATION | Sep 1, 2015 | Abandoned |
Array
(
[id] => 11993980
[patent_doc_number] => 20170298136
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-19
[patent_title] => 'METHOD FOR TREATING PSORIASIS PATIENT WHICH RECEIVED ANTI-TNF-ALPHA ANTIBODY THERAPY'
[patent_app_type] => utility
[patent_app_number] => 15/513132
[patent_app_country] => US
[patent_app_date] => 2015-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7761
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 22
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15513132
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/513132 | METHOD FOR TREATING PSORIASIS PATIENT WHICH RECEIVED ANTI-TNF-ALPHA ANTIBODY THERAPY | Aug 25, 2015 | Abandoned |
Array
(
[id] => 10706844
[patent_doc_number] => 20160052991
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-02-25
[patent_title] => 'MUTANT G-PROTEIN COUPLED RECEPTORS AND METHODS FOR SELECTING THEM'
[patent_app_type] => utility
[patent_app_number] => 14/836820
[patent_app_country] => US
[patent_app_date] => 2015-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 35
[patent_no_of_words] => 27436
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14836820
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/836820 | MUTANT G-PROTEIN COUPLED RECEPTORS AND METHODS FOR SELECTING THEM | Aug 25, 2015 | Abandoned |
Array
(
[id] => 11980855
[patent_doc_number] => 20170285009
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-05
[patent_title] => 'METHODS FOR IDENTIFYING A RECEPTOR FOR A LIGAND AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/506266
[patent_app_country] => US
[patent_app_date] => 2015-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 14276
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15506266
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/506266 | Methods for identifying a receptor for a ligand and uses thereof | Aug 24, 2015 | Issued |
Array
(
[id] => 11296657
[patent_doc_number] => 09504649
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-11-29
[patent_title] => 'Method and compositions for genetic and retinal disease'
[patent_app_type] => utility
[patent_app_number] => 14/834967
[patent_app_country] => US
[patent_app_date] => 2015-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 8418
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 127
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14834967
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/834967 | Method and compositions for genetic and retinal disease | Aug 24, 2015 | Issued |
Array
(
[id] => 10693722
[patent_doc_number] => 20160039867
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-02-11
[patent_title] => 'SINGLE-CHAIN ANTIPARALLEL COILED COIL PROTEINS'
[patent_app_type] => utility
[patent_app_number] => 14/832039
[patent_app_country] => US
[patent_app_date] => 2015-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 16854
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14832039
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/832039 | SINGLE-CHAIN ANTIPARALLEL COILED COIL PROTEINS | Aug 20, 2015 | Abandoned |
Array
(
[id] => 11851721
[patent_doc_number] => 20170226213
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-10
[patent_title] => 'Human anti-FGFR4 antibody'
[patent_app_type] => utility
[patent_app_number] => 15/503095
[patent_app_country] => US
[patent_app_date] => 2015-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 16438
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15503095
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/503095 | Human anti-FGFR4 antibody | Aug 10, 2015 | Issued |
Array
(
[id] => 12226692
[patent_doc_number] => 09913920
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-03-13
[patent_title] => 'Targeting and in vivo imaging of tumor-associated macrophages'
[patent_app_type] => utility
[patent_app_number] => 14/820368
[patent_app_country] => US
[patent_app_date] => 2015-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 64
[patent_no_of_words] => 31617
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 141
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14820368
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/820368 | Targeting and in vivo imaging of tumor-associated macrophages | Aug 5, 2015 | Issued |
Array
(
[id] => 11851710
[patent_doc_number] => 20170226203
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-10
[patent_title] => 'Anti-Orai1 Antibody'
[patent_app_type] => utility
[patent_app_number] => 15/502088
[patent_app_country] => US
[patent_app_date] => 2015-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 60
[patent_figures_cnt] => 60
[patent_no_of_words] => 40360
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15502088
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/502088 | Anti-Orai1 antibody | Aug 5, 2015 | Issued |
Array
(
[id] => 11767919
[patent_doc_number] => 09376496
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-06-28
[patent_title] => 'LLT-1 antibodies with new functional properties'
[patent_app_type] => utility
[patent_app_number] => 14/814673
[patent_app_country] => US
[patent_app_date] => 2015-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 18
[patent_no_of_words] => 22854
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 139
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14814673
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/814673 | LLT-1 antibodies with new functional properties | Jul 30, 2015 | Issued |
Array
(
[id] => 11757550
[patent_doc_number] => 20170204419
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-20
[patent_title] => 'MRGPRX2/MRGPRB2 EXPRESSING CELL BASED ASSAY TO DETECT PSEUDO-ALLERGIC DRUG REACTIONS AND TO IDENTIFY BLOCKERS TO PREVENT THE ADVERSE REACTIONS'
[patent_app_type] => utility
[patent_app_number] => 15/329383
[patent_app_country] => US
[patent_app_date] => 2015-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 38
[patent_no_of_words] => 23170
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15329383
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/329383 | MrgprX2/MrgprB2 expressing cell based assay to detect pseudo-allergic drug reactions and to identify blockers to prevent the adverse reactions | Jul 30, 2015 | Issued |
Array
(
[id] => 10162538
[patent_doc_number] => 09193755
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2015-11-24
[patent_title] => 'TFEB variants and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 14/811967
[patent_app_country] => US
[patent_app_date] => 2015-07-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 12278
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14811967
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/811967 | TFEB variants and uses thereof | Jul 28, 2015 | Issued |
Array
(
[id] => 10445983
[patent_doc_number] => 20150330998
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-11-19
[patent_title] => 'VEGF-A121 ASSAY'
[patent_app_type] => utility
[patent_app_number] => 14/811056
[patent_app_country] => US
[patent_app_date] => 2015-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5853
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14811056
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/811056 | VEGF-A121 assay | Jul 27, 2015 | Issued |
Array
(
[id] => 10445984
[patent_doc_number] => 20150330999
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-11-19
[patent_title] => 'VEGF-A121 ASSAY'
[patent_app_type] => utility
[patent_app_number] => 14/811074
[patent_app_country] => US
[patent_app_date] => 2015-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5857
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14811074
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/811074 | VEGF-A121 ASSAY | Jul 27, 2015 | Abandoned |
Array
(
[id] => 11853048
[patent_doc_number] => 20170227540
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-10
[patent_title] => 'MEMORY INVARIANT NKT CELL MARKER'
[patent_app_type] => utility
[patent_app_number] => 15/328997
[patent_app_country] => US
[patent_app_date] => 2015-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 13130
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15328997
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/328997 | Memory invariant NKT cell marker | Jul 23, 2015 | Issued |
Array
(
[id] => 11757288
[patent_doc_number] => 20170204157
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-20
[patent_title] => 'HUMAN FGFR2C EXTRACELLULAR PROTEIN AS WELL AS CODING GENE AND APPLICATION THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/327881
[patent_app_country] => US
[patent_app_date] => 2015-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 9714
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15327881
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/327881 | HUMAN FGFR2C EXTRACELLULAR PROTEIN AS WELL AS CODING GENE AND APPLICATION THEREOF | Jul 20, 2015 | Abandoned |
Array
(
[id] => 13117931
[patent_doc_number] => 10077309
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-09-18
[patent_title] => Compositions and methods for targeting of the surfactant protein A receptor
[patent_app_type] => utility
[patent_app_number] => 15/323858
[patent_app_country] => US
[patent_app_date] => 2015-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 37
[patent_no_of_words] => 14085
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 247
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15323858
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/323858 | Compositions and methods for targeting of the surfactant protein A receptor | Jul 13, 2015 | Issued |
Array
(
[id] => 11668529
[patent_doc_number] => 20170157250
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-08
[patent_title] => 'ANTIBODIES BINDING AXL'
[patent_app_type] => utility
[patent_app_number] => 15/325364
[patent_app_country] => US
[patent_app_date] => 2015-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 59996
[patent_no_of_claims] => 62
[patent_no_of_ind_claims] => 50
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15325364
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/325364 | Antibodies binding AXL | Jul 9, 2015 | Issued |
Array
(
[id] => 11671555
[patent_doc_number] => 20170160277
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-08
[patent_title] => 'IN VITRO ASSAYS FOR ASSESSING CELL AGING'
[patent_app_type] => utility
[patent_app_number] => 15/321774
[patent_app_country] => US
[patent_app_date] => 2015-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 15556
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15321774
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/321774 | In vitro assays for assessing cell aging | Jul 2, 2015 | Issued |
Array
(
[id] => 16125973
[patent_doc_number] => 10696728
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-06-30
[patent_title] => Polypeptides, related nucleic acids, and their uses for cell modulation and treatments
[patent_app_type] => utility
[patent_app_number] => 15/320349
[patent_app_country] => US
[patent_app_date] => 2015-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 13968
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15320349
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/320349 | Polypeptides, related nucleic acids, and their uses for cell modulation and treatments | Jul 1, 2015 | Issued |